World's Best Scientists 2026 revealed!
Cancer Gene Therapy
H-index 30

Cancer Gene Therapy

0929-1903

Published by: Springer

https://www.nature.com/cgt/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Genetics 109 18 19 8
Medicine 1119 107 100 21

Additional Metrics

Number of Best Scientists*: 324
Documents by Best Scientists*: 257
Top 100 Ranked Scientists*: 11
SCIMAGO H-index: 101
SCIMAGO SJR: 1.727
Impact Factor: 5

Overview

Top Research Topics at Cancer Gene Therapy?

The main points discussed in the journal deals with Cancer research, Molecular biology, Genetic enhancement, Cell culture and In vivo. The Cancer research works featured in Cancer Gene Therapy incorporate elements from Cancer cell, Cancer, Cell growth, Apoptosis and Immunology. The majority of Apoptosis studies are focused on the issues of Programmed cell death.

It covers various topics on Immunology such as Immune system, Immunotherapy, Antigen and CD8. Concepts in Suicide gene, as well as related topics in Thymidine kinase, are covered in the Molecular biology research presented in Cancer Gene Therapy. The study of Genetic enhancement encompasses disciplines such as Virology, as well as fields such as Vector (molecular biology), all of which overlap with one another.

While Cell culture is the key highlight in the journal, it also covered some subjects on Oncolytic virus and Adenoviridae. Cancer Gene Therapy focuses on In vivo as well as the interrelated topic of In vitro. Gene expression is the primary subject of Gene works presented in it.

  • Cancer research (48.30%)
  • Molecular biology (32.13%)
  • Genetic enhancement (24.11%)

What are the most cited papers published in the journal?

  • Mechanisms of resistance to TRAIL-induced apoptosis in cancer. (579 citations)
  • A comparison of gene transfer methods in human dendritic cells (323 citations)
  • Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma. (305 citations)

Research areas of the most cited articles at Cancer Gene Therapy:

The journal publications generally zeroe in on subjects such as Cancer research, Molecular biology, Genetic enhancement, In vivo and Cancer. The journal publications explore research in Cancer research alongside concepts in Immunology and other areas of study in Interleukin 12. While work presented in the journal publications provide substantial information on Molecular biology, it also covers topics in Cell culture, Transfection, Apoptosis, Antigen and Viral vector.

What topics the last edition of the journal is best known for?

  • Gene
  • Cancer
  • Internal medicine

The previous edition focused in particular on these issues:

The journal explores disciplines such as Cancer research, Downregulation and upregulation, Cancer, Metastasis and microRNA. The journal addresses concerns in Cancer research which are intertwined with other disciplines, such as Cell growth, Gene knockdown, Carcinogenesis, Cancer cell and Immune system. The journal holds forums on Downregulation and upregulation that merges themes from other disciplines such as Cell culture, Cell migration, Cell biology, Tumor progression and Gene silencing.

The research on Cancer tackled can also make contributions to studies in the areas of Cell, Genetic enhancement, Melanoma and Oncology. It addresses concerns in the field of Metastasis by exploring it in line with topics in Apoptosis which intersect with Flow cytometry and Kinase subjects. Topics in microRNA were tackled in line with various other fields like Protein kinase B, Oncogene, Transfection, Stem cell and MAPK/ERK pathway.

The most cited articles from the last journal are:

  • Revisiting the role of CD4 + T cells in cancer immunotherapy—new insights into old paradigms (91 citations)
  • Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death. (32 citations)
  • METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway. (17 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cancer Gene Therapy (based on the number of publications) are:

  • David T. Curiel (44 papers) published 1 paper at the last edition,
  • Masatoshi Tagawa (29 papers) absent at the last edition,
  • Jim Xiang (22 papers) absent at the last edition,
  • John Nemunaitis (19 papers) published 2 papers at the last edition,
  • Hirofumi Hamada (16 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Gene Therapy (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (92 papers) published 2 papers at the last edition,
  • University of Alabama at Birmingham (65 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Harvard University (44 papers) published 1 paper at the last edition, 3 less than at the previous edition,
  • French Institute of Health and Medical Research (44 papers) published 2 papers at the last edition,
  • Osaka University (42 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 5.43% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 9.20% were posted by at least one author from the top 10 institutions publishing in the journal. Another 14.94% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.69% of all publications and 55.17% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials.

    Khalil Choucair;Susan Morand;Laura Stanbery;Gerald Edelman

    (2020)
    131 Citations
  • LOX-1 and cancer: an indissoluble liaison.

    M. Murdocca;C. De Masi;S. Pucci;R. Mango

    (2021)
    75 Citations
  • CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model.

    Yu Yang Ng;Zhicheng Du;Xi Zhang;Wee Joo Chng

    (2021)
    62 Citations
  • Nanomedicine-based cancer immunotherapy: recent trends and future perspectives

    Vinoth-Kumar Lakshmanan;Vinoth-Kumar Lakshmanan;Shlok Jindal;Gopinath Packirisamy;Shreesh Ojha

    (2021)
    58 Citations
  • Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth.

    Thuy Phan;Vu H. Nguyen;Marcela S. D’Alincourt;Edwin R. Manuel

    (2020)
    53 Citations
  • Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling

    (2022)
    45 Citations
  • Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance.

    Rana Shafabakhsh;Farzaneh Arianfar;Massoud Vosough;Hamid Reza Mirzaei

    (2021)
    41 Citations
  • Clinical trials of self-replicating RNA-based cancer vaccines

    (2023)
    39 Citations
  • Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy

    Mathilde Feist;Mathilde Feist;Zhi Zhu;Enyong Dai;Enyong Dai;Congrong Ma

    (2021)
    38 Citations

Related Online Degrees & Career Pathways

For those interested in the medical field beyond studying Medicine in the USA, several related online degree programs offer flexible learning paths. Aspiring healthcare professionals can explore online sonography programs to become skilled ultrasound technicians, a critical role in diagnostic imaging.

Similarly, students seeking affordable options may consider online rad tech programs, which prepare graduates for roles as radiologic technologists, supporting diagnostic and treatment processes with medical imaging.

For those interested in nutrition and wellness, pursuing one of the best dietetics masters programs can open doors to careers in dietetics and public health, focusing on improving patient outcomes through diet management.

Additionally, many online healthcare programs, including financial aid for medical assistant programs, provide resources to help students manage educational costs, making these career paths more accessible.

Exploring these diverse programs can provide flexible and affordable alternatives or supplements to traditional medical education, expanding opportunities in healthcare support roles.

Best Scientists Contributing to This Journal

Recently Published Articles